Assessing portal hypertension in liver diseases

Expert Review of Gastroenterology and Hepatology

Volumn 7, Issue 2, 2013, Pages 141-155

  Berzigotti, Annalisa ^a,b   Seijo, Susana ^a,b   Reverter, Enric ^a,b   Bosch, Jaime ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

hepatic hemodynamics; hepatic venous pressure gradient; liver stiffness; noninvasive methods; ultrasound

Indexed keywords

ANTIVIRUS AGENT;

CHRONIC LIVER DISEASE; COLOR ULTRASOUND FLOWMETRY; COMPUTER ASSISTED TOMOGRAPHY; DECOMPENSATED LIVER CIRRHOSIS; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; ELASTOGRAPHY; ENDOSCOPIC ECHOGRAPHY; ESOPHAGUS VARICES; GASTROINTESTINAL ENDOSCOPY; GOLD STANDARD; HEPATITIS B; HEPATITIS C; HUMAN; LABORATORY TEST; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; LIVER TRANSPLANTATION; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SPLENOMEGALY; STOMACH VARICES; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; VASCULAR RESISTANCE; VEIN CATHETERIZATION;

BUDD-CHIARI SYNDROME; CHRONIC DISEASE; ENDOSCOPY, DIGESTIVE SYSTEM; ESOPHAGEAL AND GASTRIC VARICES; HEMODYNAMICS; HUMANS; HYPERTENSION, PORTAL; LIVER; LIVER CIRRHOSIS; LIVER DISEASES; MAGNETIC RESONANCE IMAGING; SPLANCHNIC CIRCULATION; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 84873156815     PISSN: 17474124     EISSN: 17474132     Source Type: Journal    
DOI: 10.1586/egh.12.83     Document Type: Review

References (86)

1. Bosch J, Abraldes JG, Berzigotti A, García-Pagan JC. The clinical use of HVPG measurements in chronic liver disease. Nat. Rev. Gastroenterol. Hepatol. 6(10), 573-582 (2009).
2. Groszmann RJ, Garcia-Tsao G, Bosch J et al.; Portal Hypertension Collaborative Group. β-blockers to prevent gastroesophageal varices in patients with cirrhosis. N. Engl. J. Med. 353(21), 2254-2261 (2005). (Pubitemid 41697288)
3. Casado M, Bosch J, García-Pagán JC et al. Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings. Gastroenterology 114(6), 1296-1303 (1998). (Pubitemid 28243916)
4. García-Pagán JC, Gracia-Sancho J, Bosch J. Functional aspects on the pathophysiology of portal hypertension in cirrhosis. J. Hepatol. 57(2), 458-461 (2012).
5. Fernández M, Semela D, Bruix J, Colle I, Pinzani M, Bosch J. Angiogenesis in liver disease. J. Hepatol. 50(3), 604-620 (2009).
6. Roskams T, Baptista A, Bianchi L et al. Histopathology of portal hypertension: a practical guideline. Histopathology 42(1), 2-13 (2003). (Pubitemid 36062561)
7. DeLeve LD, Valla DC, Garcia-Tsao G; American Association for the Study Liver Diseases. Vascular disorders of the liver. Hepatology 49(5), 1729-1764 (2009).
8. Perelló A, Escorsell A, Bru C et al. Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus-related cirrhosis. Hepatology 30(6), 1393-1397 (1999).
9. Iwao T, Toyonaga A, Ikegami M et al. Wedged hepatic venous pressure reflects portal venous pressure during vasoactive drug administration in nonalcoholic cirrhosis. Dig. Dis. Sci. 39(11), 2439-2444 (1994). (Pubitemid 24350028)
10. Maleux G, Willems E, Fieuws S et al. Prospective study comparing different indirect methods to measure portal pressure. J. Vasc. Interv. Radiol. 22(11), 1553-1558 (2011).
11. Steinlauf AF, Garcia-Tsao G, Zakko MF, Dickey K, Gupta T, Groszmann RJ. Low-dose midazolam sedation: an option for patients undergoing serial hepatic venous pressure measurements. Hepatology 29(4), 1070-1073 (1999). (Pubitemid 29168738)
12. McGee DC, Gould MK. Preventing complications of central venous catheterization. N. Engl. J. Med. 348(12), 1123-1133 (2003). (Pubitemid 36337324)
13. La Mura V, Abraldes JG, Berzigotti A et al. Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis: a clinical-hemodynamic correlation study. Hepatology 51(6), 2108-2116 (2010).
14. Okuda K, Kono K, Ohnishi K et al. Clinical study of eighty-six cases of idiopathic portal hypertension and comparison with cirrhosis with splenomegaly. Gastroenterology 86(4), 600-610 (1984). (Pubitemid 14164710)
15. Seijo S, Reverter E, Miquel R et al. Role of hepatic vein catheterisation and transient elastography in the diagnosis of idiopathic portal hypertension. Dig. Liver Dis. 44(10), 855-860 (2012).
16. Groszmann RJ, Wongcharatrawee S. The hepatic venous pressure gradient: anything worth doing should be done right. Hepatology 39(2), 280-282 (2004). (Pubitemid 38222164)
17. Gluud C, Brok J, Gong Y, Koretz RL. Hepatology may have problems with putative surrogate outcome measures. J. Hepatol. 46(4), 734-742 (2007). (Pubitemid 46420383)
18. Garcia-Tsao G, Groszmann RJ, Fisher RL, Conn HO, Atterbury CE, Glickman M. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology 5(3), 419-424 (1985). (Pubitemid 15065948)
19. Ripoll C, Groszmann RJ, Garcia-Tsao G et al.; Portal Hypertension Collaborative Group. Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis. J. Hepatol. 50(5), 923-928 (2009).
20. Merkel C, Bolognesi M, Bellon S et al. Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices. Gastroenterology 102(3), 973-979 (1992).
21. Stanley AJ, Robinson I, Forrest EH, Jones AL, Hayes PC. Haemodynamic parameters predicting variceal haemorrhage and survival in alcoholic cirrhosis. QJM 91(1), 19-25 (1998). (Pubitemid 28041003)
22. Moitinho E, Escorsell A, Bandi JC et al. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology 117(3), 626-631 (1999). (Pubitemid 29409248)
23. Ripoll C, Bañares R, Rincón D et al. Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD Era. Hepatology 42(4), 793-801 (2005). (Pubitemid 41401116)
24. Bruix J, Castells A, Bosch J et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 111(4), 1018-1022 (1996). (Pubitemid 26327605)
25. Llovet JM, Fuster J, Bruix J. Intention-totreat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 30(6), 1434-1440 (1999).
26. Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis. N. Engl. J. Med. 362(9), 823-832 (2010).
27. La Mura V, Abraldes JG, Raffa S et al. Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension. J. Hepatol. 51(2), 279-287 (2009).
28. Villanueva C, Aracil C, Colomo A et al. Acute hemodynamic response to β-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding. Gastroenterology 137(1), 119-128 (2009).
29. Rincon D, Ripoll C, Lo Iacono O et al. Antiviral therapy decreases hepatic venous pressure gradient in patients with chronic hepatitis C and advanced fibrosis. Am. J. Gastroenterol. 101(10), 2269-2274 (2006). (Pubitemid 44477554)
30. Roberts S, Gordon A, McLean C et al. Effect of sustained viral response on hepatic venous pressure gradient in hepatitis Crelated cirrhosis. Clin. Gastroenterol. Hepatol. 5(8), 932-937 (2007). (Pubitemid 47127019)
31. Burroughs AK, Groszmann R, Bosch J et al. Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point? Gut 50(3), 425-427 (2002). (Pubitemid 34161063)
32. Carrión JA, Navasa M, García-Retortillo M et al. Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study. Gastroenterology 132(5), 1746-1756 (2007). (Pubitemid 46695723)
33. de Franchis R; Baveno V Faculty. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J. Hepatol. 53(4), 762-768 (2010).
34. NIEC. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. N. Engl. J. Med. 319, 983-989 (1988).
35. Sarin SK, Lahoti D, Saxena SP, Murthy NS, Makwana UK. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology 16(6), 1343-1349 (1992).
36. Payen JL, Calès P, Voigt JJ et al. Severe portal hypertensive gastropathy and antral vascular ectasia are distinct entities in patients with cirrhosis. Gastroenterology 108(1), 138-144 (1995).
37. Spahr L, Villeneuve JP, Dufresne MP et al. Gastric antral vascular ectasia in cirrhotic patients: absence of relation with portal hypertension. Gut 44(5), 739-742 (1999). (Pubitemid 29195927)
38. de Franchis R. Non-invasive (and minimally invasive) diagnosis of oesophageal varices. J. Hepatol. 49(4), 520-527 (2008).
39. Ganc RL, Malheiros CA, Nakakubo S, Szutan LA, Ganc AJ. Small-bowel lesions caused by portal hypertension of schistosomal origin: a capsule endoscopy pilot study. Gastrointest. Endosc. 71(4), 861-866 (2010).
40. Iwase H, Suga S, Morise K, Kuroiwa A, Yamaguchi T, Horiuchi Y. Color Doppler endoscopic ultrasonography for the evaluation of gastric varices and endoscopic obliteration with cyanoacrylate glue. Gastrointest. Endosc. 41(2), 150-154 (1995).
41. Bosch J, Bordas JM, Rigau J et al. Noninvasive measurement of the pressure of esophageal varices using an endoscopic gauge: comparison with measurements by variceal puncture in patients undergoing endoscopic sclerotherapy. Hepatology 6(4), 667-672 (1986). (Pubitemid 16038186)
42. Nevens F, Sprengers D, Feu F, Bosch J, Fevery J. Measurement of variceal pressure with an endoscopic pressure sensitive gauge: validation and effect of propranolol therapy in chronic conditions. J. Hepatol. 24(1), 66-73 (1996). (Pubitemid 26037206)
43. Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD; American Association for the Study of Liver Diseases. Liver biopsy. Hepatology 49(3), 1017-1044 (2009).
44. Bedossa P. Liver biopsy. Gastroenterol. Clin. Biol. 32(6 Suppl. 1), 4-7 (2008).
45. Nagula S, Jain D, Groszmann RJ, Garcia-Tsao G. Histological-hemodynamic correlation in cirrhosis - a histological classification of the severity of cirrhosis. J. Hepatol. 44(1), 111-117 (2006). (Pubitemid 41772524)
46. Calvaruso V, Burroughs AK, Standish R et al. Computer-assisted image analysis of liver collagen: relationship to Ishak scoring and hepatic venous pressure gradient. Hepatology 49(4), 1236-1244 (2009).
47. Sethasine S, Jain D, Groszmann RJ, Garcia-Tsao G. Quantitative histologicalhemodynamic correlations in cirrhosis. Hepatology 55(4), 1146-1153 (2012).
48. de Bruyn G, Graviss EA. A systematic review of the diagnostic accuracy of physical examination for the detection of cirrhosis. BMC Med. Inform. Decis. Mak. 1, 6 (2001).
49. Berzigotti A, Gilabert R, Abraldes JG et al. Noninvasive prediction of clinically significant portal hypertension and esophageal varices in patients with compensated liver cirrhosis. Am. J. Gastroenterol. 103(5), 1159-1167 (2008). (Pubitemid 351677998)
50. Abraldes JG, Villanueva C, Bañares R et al.; Spanish Cooperative Group for Portal Hypertension and Variceal Bleeding. Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy. J. Hepatol. 48(2), 229-236 (2008).
51. Zaman A, Hapke R, Flora K, Rosen HR, Benner K. Factors predicting the presence of esophageal or gastric varices in patients with advanced liver disease. Am. J. Gastroenterol. 94(11), 3292-3296 (1999).
52. Thabut D, Imbert-Bismut F, Cazals-Hatem D et al. Relationship between the fibrotest and portal hypertension in patients with liver disease. Aliment. Pharmacol. Ther. 26(3), 359-368 (2007). (Pubitemid 47063142)
53. Nøjgaard C, Johansen JS, Christensen E, Skovgaard LT, Price PA, Becker U; EMALD Group. Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease. J. Hepatol. 39(2), 179-186 (2003). (Pubitemid 36920552)
54. Guéchot J, Serfaty L, Bonnand AM, Chazouillères O, Poupon RE, Poupon R. Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosis. J. Hepatol. 32(3), 447-452 (2000). (Pubitemid 30136860)
55. Castera L, Pinzani M, Bosch J. Noninvasive evaluation of portal hypertension using transient elastography. J. Hepatol. 56(3), 696-703 (2012).
56. Carrión JA, Navasa M, Bosch J, Bruguera M, Gilabert R, Forns X. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transpl. 12(12), 1791-1798 (2006). (Pubitemid 44911805)
57. Berzigotti A. Transient elastography and prognosis of cirrhosis. Hepatology 55(5), 1629-1631 (2012).
58. Robic MA, Procopet B, Métivier S et al. Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study. J. Hepatol. 55(5), 1017-1024 (2011).
59. Llop E, Berzigotti A, Reig M et al. Assessment of portal hypertension by transient elastography in patients with compensated cirrhosis and potentially resectable liver tumors. J. Hepatol. 56(1), 103-108 (2012).
60. Vizzutti F, Arena U, Romanelli RG et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology 45(5), 1290-1297 (2007). (Pubitemid 46775793)
61. Castéra L, Foucher J, Bernard PH et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology 51(3), 828-835 (2010).
62. Yin M, Chen J, Glaser KJ, Talwalkar JA, Ehman RL. Abdominal magnetic resonance elastography. Top. Magn. Reson. Imaging 20(2), 79-87 (2009).
63. Friedrich-Rust M, Wunder K, Kriener S et al. Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography. Radiology 252(2), 595-604 (2009).
64. Talwalkar JA, Yin M, Venkatesh S et al. Feasibility of in vivo MR elastographic splenic stiffness measurements in the assessment of portal hypertension. AJR. Am. J. Roentgenol. 193(1), 122-127 (2009).
65. Colecchia A, Montrone L, Scaioli E et al. Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis. Gastroenterology 143(3), 646-654 (2012).
66. Hirooka M, Ochi H, Koizumi Y et al. Splenic elasticity measured with real-time tissue elastography is a marker of portal hypertension. Radiology 261(3), 960-968 (2011).
67. Berzigotti A, Piscaglia F; EFSUMB Education and Professional Standards Committee. Ultrasound in portal hypertension - part 2 - and EFSUMB recommendations for the performance and reporting of ultrasound examinations in portal hypertension. Ultraschall Med. 33(1), 8-32; quiz 30 (2012).
68. Berzigotti A, Abraldes JG, Tandon P et al. Ultrasonographic evaluation of liver surface and transient elastography in clinically doubtful cirrhosis. J. Hepatol. 52(6), 846-853 (2010).
69. Berzigotti A, Piscaglia F. Ultrasound in portal hypertension - part 1. Ultraschall Med. 32(6), 548-68; quiz 569 (2011).
70. Rossi S, Rosa L, Ravetta V et al. Contrast- enhanced versus conventional and color Doppler sonography for the detection of thrombosis of the portal and hepatic venous systems. AJR. Am. J. Roentgenol. 186(3), 763-773 (2006). (Pubitemid 46110020)
71. Abraldes JG, Gilabert R, Turnes J et al. Utility of color Doppler ultrasonography predicting tips dysfunction. Am. J. Gastroenterol. 100(12), 2696-2701 (2005).
72. Van Beers BE, Materne R, Annet L et al. Capillarization of the sinusoids in liver fibrosis: noninvasive assessment with contrast-enhanced MRI in the rabbit. Magn. Reson. Med. 49(4), 692-699 (2003). (Pubitemid 36389979)
73. Annet L, Materne R, Danse E, Jamart J, Horsmans Y, Van Beers BE. Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension. Radiology 229(2), 409-414 (2003). (Pubitemid 37310826)
74. Giannini E, Botta F, Borro P et al. Platelet count/spleen diameter ratio: proposal and validation of a noninvasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis. Gut 52(8), 1200-1205 (2003). (Pubitemid 36877436)
75. Kim BK, Han KH, Park JY et al. A liver stiffness measurement-based, noninvasive prediction model for high-risk esophageal varices in B-viral liver cirrhosis. Am. J. Gastroenterol. 105(6), 1382-1390 (2010).
76. Ripoll C, Groszmann R, Garcia-Tsao G et al.; Portal Hypertension Collaborative Group. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology 133(2), 481-488 (2007). (Pubitemid 47187350)
77. Lebrec D, De Fleury P, Rueff B, Nahum H, Benhamou JP. Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology 79(6), 1139-1144 (1980). (Pubitemid 11250452)
78. Vorobioff J, Groszmann RJ, Picabea E et al. Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: a 10-year prospective study. Gastroenterology 111(3), 701-709 (1996). (Pubitemid 26293235)
79. Gluud C, Henriksen JH, Nielsen G. Prognostic indicators in alcoholic cirrhotic men. Hepatology 8(2), 222-227 (1988).
80. Berzigotti A, Rossi V, Tiani C et al. Prognostic value of a single HVPG measurement and Doppler-ultrasound evaluation in patients with cirrhosis and portal hypertension. J. Gastroenterol. 46(5), 687-695 (2011).
81. Merkel C, Marin R, Sacerdoti D et al. Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Hepatology 31(2), 324-329 (2000). (Pubitemid 30078595)
82. Rincon D, Lo Iacono O, Ripoll C et al. Prognostic value of hepatic venous pressure gradient for in-hospital mortality of patients with severe acute alcoholic hepatitis. Aliment. Pharmacol. Ther. 25(7), 841-848 (2007). (Pubitemid 46434912)
83. Sersté T, Bourgeois N, Lebrec D, Evrard S, Devière J, Le Moine O. Relationship between the degree of portal hypertension and the onset of spontaneous bacterial peritonitis in patients with cirrhosis. Acta Gastroenterol. Belg. 69(4), 355-360 (2006).
84. Lemoine M, Katsahian S, Ziol M et al. Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis. Aliment. Pharmacol. Ther. 28, 1102-1110 (2008).
85. Bureau C, Metivier S, Peron JM et al. Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease. Aliment Pharmacol. Ther. 27, 1261-1268 (2008). (Pubitemid 351697282)
86. Sanchez-Condé M, Miralles P, Bellon JM et al. Use of transient elastography (FibroScan®) for the noninvasive assessment of portal hypertension in HIV/ HCV-coinfected patients. J. Viral Hepat. 18, 685-691 (2011).